The DENN domain is an evolutionary conserved protein module found in all eukaryotes and serves as an exchange factor for Rab-GTPases to regulate diverse cellular functions. Variants in DENND1B are associated with development of childhood asthma and other immune disorders. To understand how DENND1B may contribute to human disease, Dennd1b À/À mice were generated and exhibit hyper-allergic responses following antigen challenge. Dennd1b À/À T H 2, but not other T H cells, exhibit delayed receptor-induced T cell receptor (TCR) downmodulation, enhanced TCR signaling, and increased production of effector cytokines. As DENND1B interacts with AP-2 and Rab35, T H 2 cells deficient in AP-2 or Rab35 also exhibit enhanced TCR-mediated effector functions. Moreover, human T H 2 cells carrying asthma-associated DENND1B variants express less DENND1B and phenocopy Dennd1b À/À T H 2 cells. These results provide a molecular basis for how DENND1B, a previously unrecognized regulator of TCR downmodulation in T H 2 cells, contributes to asthma pathogenesis and how DENN-domaincontaining proteins may contribute to other human disorders.
INTRODUCTION
The differentially expressed in normal and neoplastic cells (DENN) domain encodes an $400 amino acid protein module found in evolutionary ancient species, including Schizosaccharymyces pombe, Arabidopsis thaliana, Caenorhabditis elegans, and Drosophila melanogaster, as well as in rodents and primates (reviewed in Marat et al., 2011) . The DENN domain interacts with members of the Rab family of small GTPases and functions enzymatically as Rab guanine nucleotide exchange factor (GEF) (Yoshimura et al., 2010) . The DENND1A-1C (also known as CONNECDENN 1-3) family contains an amino-terminal tripartite DENN domain and carboxy-terminal consensus binding motifs for clathrin and the clathrin adaptor AP-2 (Levivier et al., 2001; Wu et al., 2011) . Both DENND1A and 1B are GEFs for Rab35, a key regulator of endocytic recycling, while DENND1C is also a GEF for Rab35 and uniquely activates Rab13 to regulate the actin cytoskeleton (Kouranti et al., 2006; Sato et al., 2008; Yoshimura et al., 2010; Marat et al., 2012) . DENN domain-containing proteins have been implicated in diverse cellular functions including receptor recyling, synaptic vesicle endocytosis, controlling polarized secretion of proteins, and autophagy (Marat et al., 2011; Xu et al., 2015) . In Arabidopsis, DENN domain containing SCD1 controls cytokinesis, cell expansion in stomata development, and resistance to bacterial infection (Falbel et al., 2003; Korasick et al., 2010) . In C. elegans, RME-4, an ortholog of DENND1A, serves as a GEF for RME-5, an ortholog of Rab35 (Sato et al., 2008) . rme-4 and rme-5 mutants demonstrate defects in recycling of RME-2 yolk receptors from the recycling endosome to the plasma membrane.
There are 18 human DENN domain-containing proteins and their alternative spliced variants. Missense mutations, chromosomal translocations, and altered levels of expression have been described in association with neurologic disorders, ocular disorders, and cancers (reviewed in Marat et al., 2011) . Genomewide association studies have recently linked single nucleotide polymorphisms (SNPs) at the DENND1B locus to development of asthma in young children (Sleiman et al., 2010) . Two subsequent studies of older children and adults have not found this linkage (Moffatt et al., 2010; Ferreira et al., 2011) . These differences may reflect the different ages of asthmatic populations studied since DENND1B gene variants have recently been reported to be associated with elevated exhaled nitric oxide levels in healthy neonates, a phenotype associated with wheezing illnesses early in life and a family history of paternal atopy (Chawes et al., 2010 (Chawes et al., , 2015 . In addition, variants in DENND1B have also been described in association with chronic cavitary pulmonary aspergillosis, primary biliary cirrhosis, and Crohn's disease (Franke et al., 2010; Liu et al., 2010 Liu et al., , 2012 Mells et al., 2011; Smith et al., 2014) . While these genome-wide association studies link DENND1B with human disorders, the mechanistic basis of how DENND1B causes disease is unknown. Understanding how DENND1B contributes to childhood asthma may also provide insights into how this evolutionarily conserved family of proteins may regulate other biological systems and contribute to human disorders.
RESULTS

DENND1B-Deficient Mice Accumulate Peripheral Effector/Memory T cells with Age
To understand how DENN1B contributes to disease, Dennd1b À/À mice were generated by deletion of exon 6 of the DENND1B gene ( Figure S1A ). Generation of Dennd1b À/À mice was confirmed by PCR analysis of genomic DNA ( Figure S1B ), qRT-PCR with primers derived from exons 4 and 5 of Dennd1b mRNA ( Figure S1C ), and western blot analysis ( Figure S1D ). Dennd1b À/À mice were developmentally normal and fertile.
Analysis of immune cell numbers of Dennd1b À/À mice (age, 5 weeks-7 months) was normal ( Figure S2A ). However, older Dennd1b À/À mice (R7 months) accumulated more splenic and lymph node (LN) CD4 + and CD8 + effector/memory T cells (Figures S2B and S2C) . Cellular composition of thymocytes and bone marrow (BM) of Dennd1b À/À mice were comparable to Dennd1b +/+ littermates at all ages examined (5 weeks-7 months, data not shown). Dennd1b mRNA is expressed in a subset of dendritic cells (DCs) and hypothesized to regulate adaptive immunity and contribute to asthma pathophysiology (Su et al., 2002; Lindstedt et al., 2005; Sleiman et al., 2010 Figure S3C ).
Analysis of Dennd1b
À/À naive T cells did not reveal any defects in TCR-mediated activation. Surface levels of CD69 and CD25 ( Figure S4A ), as well as IL-2 production ( Figure S4B) Figure S4E ; data not shown). No differences were observed when Dennd1b
T H 2 cells were treated with phorbol ester (PMA) and calcium ionophore, signals that bypass the proximal TCR signaling pathway ( Figure S4F ). Finally, no alterations in T H 1, T H 17, or T H 0 cells were observed with loss of DENND1B when stimulated within this more physiologic antigen/APC context. Similarly, no differences in IL-2 were observed in any differentiated T lineage cells ( Figure S4E ). Engagement of the TCR results in the sequential activation of cytoplasmic LCK and ZAP-70 protein tyrosine kinases (PTKs) that promotes tyrosine phosphorylation not only of the PTKs, but also of the CD3 and z receptor subunits, SLP-76 adaptor, and PLCg1 and VAV effector enzymes to facilitate increases in free cytoplasmic calcium, regulate actin reorganization, and downstream activation of ERK and NF-kB signaling pathways (reviewed in Brownlie and Zamoyska, 2013 Alcover and Alarcó n, 2000; Geisler, 2004) . Upon receptor activation, surface TCRs undergo downmodulation and are targeted for intracellular degradation through lysosomes and proteosomes, a mechanism thought to attenuate TCR signaling (Telerman et al., 1987; Valitutti et al., 1995 Valitutti et al., , 1996 Valitutti et al., , 1997 While TfR internalization was not affected by loss of DENND1B, we assessed whether other receptors known to play important roles in T H 2 functions might be regulated by DENND1B. Internalization of both the ligand-binding IL-4Ra subunit and associated signaling common g chain was similar between Dennd1b +/+ and Dennd1b À/À T H 2 cells in response to IL-4 ( Figure S5E ). In addition, IL-4R activation, as measured by tyrosine phosphorylation of STAT6 and JAK1, was similar These results suggest a selective effect of DENND1B on TCR trafficking in T H 2 cells likely contributes to the augmented T H 2 phenotype, although it does not exclude the possibility that other receptors may also contribute.
DENND1B-Deficient Mice Have Increased Antigen-Induced Allergic Responses
Given the association of SNPs in DENND1B in early childhood asthma (Sleiman et al., 2010) , we challenged primed Dennd1b (Sleiman et al., 2010) . Naive CD4 T cells (CD45RA + CD45RO À ) were purified from human peripheral blood mononuclear cells (PBMCs) and T H 1 or T H 2 cultures were differentiated under polarizing conditions for 12 days. Due to sample size considerations, we pooled homozygous protective (A/A) and heterozygous (A/C) donors for analysis, termed ''protective allele donors.'' T H 2 cells from Caucasian protective allele donors had decreased IL-4 and IL-13 production following TCR stimulation when compared to T H 2 cells derived from Caucasian donors homozygous for the major allele (C/C) with higher risk of developing asthma ( Figure 5A ). Similarly, transcription of Il4 and Il13 was also reduced in T H 2 cells from protective allele donors (Figure 5B) . In contrast, IFN-g production from T H 1 cultures and IL-2 production from T H 1 or T H 2 cultures were similar between donors of both groups ( Figure 5A ). Similar to Dennd1b À/À T H 2 cells, T H 2 cells from C/C donors with higher levels of T H 2 cytokine production demonstrated delayed downmodulation of surface TCRs when compared to protective allele donors (Figure 5C ). TfR internalization in T H 2 and T H 1 cells as well as TCR downmodulation in T H 1 cells was indifferent between C/C, C/A, or A/A donors. Western blot analysis for DENND1B from PBMC-derived T H 2 cultures demonstrated that protective allele donors (A/A and A/C) expressed higher levels of DENND1B protein compared to C/C donors ( Figure 5D ). Moreover, expression levels of DENND1B protein were positively correlated with surface TCR downmodulation (r = 0.81) and negatively correlated with IL-4 (r = À0.78) and IL-13 (r = À0.63) production from stimulated T H 2 cells ( Figure 5E ; data not shown). Together, these data indicate that T H 2 cells derived from Caucasian donors carrying protective alleles for development of childhood asthma have higher levels of DENND1B protein expression, faster rates of TCR-mediated downmodulation and lower levels of T H 2 cytokine production when compared to C/C donors. PBMC-derived T H 1 cells also demonstrated that protective A allele donors expressed higher levels of DENND1B protein ( Figure 5F ). However, expression of DENND1B was not correlated with either IFN-g production (r = À0.10) or TCR downmodulation rate (r = 0.07) ( Figure 5G ).
In both PBMC-derived T H 2 and T H 1 differentiated cultures, DENND1B protein expression levels correlated with DENND1B mRNA levels (r = 0.61 and 0.59, respectively) ( Figure 5H ). To further examine the effect of SNP rs2786098 on DENND1B expression we performed expression quantitative trait loci (eQTL) analysis based on SNP genotyping and RNA-sequencing data from samples collected by the GTEx Consortium (2015) (PMID 25954001). Our eQTL analysis was consistent with the western blot analysis of our donors, showing a genotypic effect in which number of minor alleles corresponded to higher mRNA levels of DENND1B in whole blood (Bonferroni corrected p = 1.4 3 10 À4 ) ( Figure 5I ). In contrast, ZAP70 mRNA levels were comparable among A/C, A/C, and C/C donors. Together, these data suggest that T H 2 cells derived from donors with A/A or A/C rs2786098 alleles have higher DENND1B protein and DENND1B mRNA levels and produce less T H 2 effector cytokines when compared to C/C donor-derived T H 2 cells. We further extended our analysis by reconstitution of DENND1B in C/C donors or gene knockdown of DENND1B in 
(legend continued on next page)
A/A donors ( Figures S7A-S7F ). Transfection of wild-type DENND1B in T H 2 cells derived from C/C donors resulted an $3-fold increase of DENND1B protein expression, which was $75% of DENND1B levels in A/A T H 2 cells ( Figure S7A ). Expression of DENND1B resulted in greater TCR downmodulation at 5 min following TCR activation and decreased IL-4 and IL-13 production ( Figures S7B and S7C) . Conversely, gene knockdown of DENND1B by transfection of Dennd1b small interfering RNA (siRNA) in T H 2 cells from A/A donors resulted in an $80% decrease of DENND1B protein expression ( Figure S7D ). Correspondingly, TCR downmodulation was delayed at 5 min following TCR activation and IL-4 and IL-13 production were enhanced ( Figures S7E and S7F) . Consistent with previous results, IL-2 production was unaffected in both experimental systems ( Figures S7C and S7F ). Figure 6G ). Conversely, IL-2 production was not affected with Rab35 siRNA knockdown. IFN-g and IL-2 production from Dennd1b +/+ T H 1 cells was not affected by Rab35 knockdown ( Figure 6H ). Transfection of an independent set of Rab35 siRNA produced similar results (data not shown). Hence, like DENND1B, Rab35 also appears to play an important role in facilitating TCR downmodulation in T H 2, but not T H 1, cells and in turn, regulate T H 2 effector cytokine production.
Gene Knockdown of Clathrin Adaptor AP-2 Results in Delayed Surface TCR Downmodulation and Increased Cytokine Production in Both Mouse T H 1 and T H 2 Cells Clathrin adaptor AP-2 interacts with dileucine motifs within the CD3 ε and g subunits and facilitates TCR internalization (Dietrich et al., 1994 (Dietrich et al., , 1997 . Since DENND1B interacts with AP-2 and clathrin (Allaire et al., 2006; Marat and McPherson, 2010) , we examined whether knockdown of AP-2 had similar effects on T H 2 cells as DENND1B deficiency. Transfection of AP-2 siRNAs in Dennd1b +/+ T H 2 cells resulted in $90% decrease in AP-2 protein levels ( Figure 6I ). Consistent with the previously recognized role of clathrin/AP-2 in TCR internalization (Dietrich et al., 1994 (Dietrich et al., , 1997 , knockdown of AP-2 resulted in a sustained decrease in TCR as well as TfR internalization ( Figures 6J, 6K , and S7H).
As compared with Dennd1b À/À T H 2 cells or with Rab35 knockdown in T H 2 cells, AP-2 knockdown resulted in a sustained reduction in TCR internalization that persisted even 30 min following TCR activation. This sustained decrease in TCR internalization was observed with both anti-CD3/28 mAb and cognate antigen/APC-mediated T cell activation. Unlike T H 1 cells lacking DENND1B or with decreased Rab35 expression that exhibit normal TCR and TfR internalization ( Figures 3A, 3B , 6E, 6F, S5C, S5D, and S7G), knockdown of AP-2 in Dennd1b
T H 1 cells resulted in a sustained decrease in TCR and TfR internalization ( Figures 6L-6N and S7H ). In turn, AP-2 knockdown resulted in increased production of IL-4, IL-5, and IL-13 in T H 2 cells ( Figure 6O ), as well as increased IFN-g secretion in T H 1 cells (Figure 6P ). Similar to loss of DENND1B or Rab35 in mouse T H 2 cells, AP-2 knockdown did not affect IL-2 production in either mouse T H 1 or T H 2 cells ( Figures 6O and 6P ).
T H 2 TCR Downmodulation and Effector Cytokine Secretion Are Regulated by DENND1B's Interaction with AP-2/Clathrin and Its GEF Function
Since DENND1B interacts with Rab35 and AP-2 in fibroblasts and epithelial cells (Allaire et al., 2006 (Allaire et al., , 2010 Marat and McPherson, 2010; Yoshimura et al., 2010) , we examined DENND1B's potential interacting proteins in T H 2 cells. In resting Dennd1b +/+ murine T H 2 cells, DENND1B co-immunoprecipitated with AP-2a, Rab35 and CD3ε ( Figures 7A and S7I ). Similar interactions were observed in T H 1, T H 17, and T H 0 cells. However, TCR activation resulted in increased association of Rab35 and CD3ε with DENND1B only in T H 2 cells. No increased association of Rab35 or CD3ε with DENND1B was detected in T H 1, T H 17 or T H 0 cells, despite comparable levels of DENND1B, AP2a, Rab35 and CD3ε in resting and activated T H cells ( Figure S7I ).
To further dissect the functional requirements for DENND1B's interactions with Rab35 and AP-2a/clathrin in T H 2 cells, we generated DENND1B mutants that could not interact with AP-2 and clathrin (K482A + DLL > AAA 547-549) or unable to facilitate guanine nucleotide exchange (G246D) (Morgan et al., 2000; Sato et al., 2008; Marat and McPherson, 2010) . Wild-type or mutant DENND1B cDNAs were expressed in Dennd1b À/À T H 2 cells through transient transfection and analyzed for TCR downmodulation and cytokine production following TCR activation. All cDNAs were expressed at comparable levels ( Figure 7B , lanes 3-5). Expression of wild-type DENND1B restored TCR downmodulation in Dennd1b minimal effects in restoring TCR downmodulation ( Figure 7C) . Correspondingly, T H 2 cells expressing either DENND1B mutant produce more IL-4, IL-5, and IL-13 when compared to T H 2 cells reconstituted with wild-type DENND1B ( Figure 7D ). As expected, TCR-mediated IL-2 secretion was comparable in all conditions and no differences were observed when cells were treated with PMA and ionomycin ( Figure S7J) . Hence, the interactions of DENND1B with AP-2/clathrin as well as its ability to facilitate Rab35 GTP exchange are required for optimal regulation of surface TCR complexes in T H 2 cells.
DISCUSSION
Duration of signaling by activated receptor complexes shapes the biological fate of many ligand-receptor interactions. While gain-or loss-of-function in key components of receptor signaling cascades can alter the biologic output to cause disease, alterations in receptor internalization, recycling, and degradation can also contribute to disease by modifying duration or subcellular locale of signaling (reviewed in Brodsky, 2012) . We describe here a previously unrecognized mechanism by which DENND1B controls efficient downmodulation of surface TCRs in T H 2 cells and when dysregulated, alters surface TCR dynamics to prolong signaling, enhances T H 2 effector functions and promotes allergic asthma.
Studies utilizing a breadth of biochemical, cellular, pharmacological, genetic, and imaging techniques have provided a deep understanding of how T cells engage APCs to initiate a productive T cell response (reviewed in Bromley et al., 2001; Balagopalan et al., 2009) . In resting T cells, TCRs are pre-clustered within the plasma membrane and are dynamically regulated through a continuous process of endocytosis and recycling. Activation of T cells results in the formation of an immunologic synapse characterized by a central supramolecular activation cluster (cSMAC) enriched for TCRs. The cSMAC serves as a nidus for the formation of signaling complexes as downstream signaling effectors are recruited to activated TCRs. Downregulation and internalization of surface TCRs serve as important modes by which to control the duration of TCR signaling (Valitutti et al., 1995 (Valitutti et al., , 1996 and occurs through a multitude of mechanisms including receptor internalization, decreased recycling from endosomes, and increased degradation through lysosomal and proteasomal pathways (Valitutti et al., 1997; Liu et al., 2000) . Internalization of TCRs is mediated through both clathrin-dependent and independent mechanisms. The CD3g subunit encodes an AP-2 binding DxxxLL binding motif that links the TCR to the clathrin machinery (Dietrich et al., 1994 (Dietrich et al., , 1997 . Mice deficient in genes controlling TCR internalization or degradation (e.g., Cbl-b, c-Cbl, and CD2AP) have increased surface TCRs and enhanced TCR signaling (Murphy et al., 1998; Naramura et al., 1998; Bachmaier et al., 2000 , Lee et al., 2003 . This multitude of mechanisms provides a T cell with the ability to fine-tune signaling at the immunological synapse.
Our studies here reveal a previously unrecognized mechanism by which DENND1B regulates surface TCR dynamics to finetune T H 2 cell signaling and effector functions. Dennd1b À/À T H 2 cells exhibit delayed TCR downmodulation following TCR activation that is associated with enhanced TCR signaling and greater transcriptional activation and secretion of T H 2-associated cytokines IL-4, IL-5, and IL-13. These cellular and biochemical changes were consistent with the enhanced in vivo T H 2-mediated inflammation observed in Dennd1b À/À mice when challenged with aerosolized antigen. That Dennd1b loxp/loxp 3 CD4-Cre mice deficient in DENND1B in T cells demonstrate similar exacerbated inflammatory responses supports a requisite role of DENND1B in T H 2 cells, but does not exclude additional functions of DENND1B in other cell types. That DENND1B specifically regulates T H 2 cells provides an intriguing mechanistic basis to explain the genetic association observed with DENND1B gene variants in early childhood asthma and neonates with elevated pulmonary nitric oxide (Sleiman et al., 2010; Chawes et al., 2015) . Similar to Dennd1b À/À T H 2 cells, human T H 2 cells derived from the major DENND1B rs2786098 allelic variant (C/C), with increased risk for asthma in Europeans, demonstrate delayed TCR downmodulation following receptor activation and increased transcription and secretion of IL-4 and IL-13 T H 2 cytokines. Consistent with a loss-of-function phenotype, T H 2 cells encoding the major C/C variant express lower levels of DENND1B protein and mRNA when compared to T H 2 cells encoding the A/A variant. Additionally, DENND1B protein levels negatively correlate with surface TCR levels and and T H 2 cytokine secretion following TCR activation. Together, our data identify a highly specialized mechanism in T H 2 cells by which DENND1B controls an early phase of TCR downmodulation following receptor engagement and also by which the major rs2786098 SNP DENND1B variant (C/C), associated with an increased risk of childhood asthma, mimics loss of DENND1B function to provide a mechanistic basis for how DENND1B SNPs may contribute to asthma pathogenesis. DENND1B forms a macromolecular complex with AP-2, Rab35, and CD3ε in T H 0, T H 1, T H 2, and T H 17 cells. However, TCR activation results in further enhanced association of Rab35 and CD3ε with DENND1B only in T H 2 cells. The interaction of DENND1B with Rab35 and AP-2/clathrin are requisite See also Figure S6 . for DENND1B function in T H 2 cells as expression of mutant DENND1B molecules, unable to facilitate Rab35-GTP exchange or interact with AP-2/clathrin, are unable to restore optimal desensitization of TCR signaling in Dennd1b À/À T H 2 cells. In resting Jurkat T cells, Rab35 is expressed at the plasma membrane and in intracellular vesicles where it co-localizes with TCR and TfR (Patino-Lopez et al., 2008) . Upon T cell activation, Rab35 is recruited to the IS and co-localizes with the TCR z chain. Expression of a dominant-negative form of Rab35 (Rab35-S22N) decreases TCR enrichment at the IS and interferes with Jurkat T cell:APC conjugate formation. Additionally, knockdown of EPI64C (TBC1D10C), a GTP-ase activating protein (GAP) for Rab35, also results in impaired Jurkat T cell:APC conjugate formation. Our data suggest a working model in which DENND1B contributes to an early phase of TCR downmodulation in T H 2 cells. However, TCR internalization in T H 2 cells still occurs through DENND1B-and Rab35-independent mechanisms since TCR internalization is normal by 30 min following activation in Dennd1b À/À T H 2 cells or with Rab35 knockdown. These DENND1B-and Rab35-independent mechanisms, however, are likely to be AP-2-dependent given the more sustained effects on TCR downmodulation observed with AP-2 knockdown in T H 2 cells and since AP-2 knockdown in Dennd1b +/+ or Dennd1b
T H 2 cells demonstrated comparable effects on TCR downmodulation (data not shown). Rab35 has been implicated in recycling of TfR, MHC class I, and RME-2 yolk receptors from endosomes to the plasma membrane and gain-of-function Rab35 mutants alter the subcellular localization of growth factor receptors to constitutively activate Akt to promote oncogenesis, (Kouranti et al., 2006; Patino-Lopez et al., 2008; Sato et al., 2008; Allaire et al., 2010; Wheeler et al., 2015) . Consistent with the established role of Rab35 in receptor recycling, Rab35 knockdown in T H 2 cells interferes with TCR recycling (data not shown). In contrast, TCR recycling in Dennd1b À/À T H 2 cells is not affected (data not shown). Further dissection of the temporal assembly of the DENND1B/AP2-clathrin/Rab35 molecular complex in regulating TCR internalization and recycling will provide greater insights. A surprising finding in our studies was the specificity of DENND1B and Rab35 effects on T H 2 cells. This selective effect on T H 2 cells was not due to differential expression of DENND1B, AP-2, or Rab35 in T H subsets ( Figure 2E ) and likely reflects the preferential TCR-inducible increase in DENND1B association with Rab35 and the TCR CD3ε subunit ( Figure 7A ). Additional studies are underway to determine if there are unique adaptors or post-translational modifications that preferentially permits DENND1B to link to the TCR in T H 2 cells. Since TCR downmodulation occurs in all T H subsets and AP-2 knockdown compromises TCR internalization in T H 0, T H 1, and T H 2 cells, why is there a specific effect of DENND1B on T H 2 versus other T H -lineage cells? First, other DENN domain containing proteins may contribute specific or redundant functions in non-T H 2 subtypes. Both DENND1A and DENND1C also interact with Rab35. DENND1A has been implicated in synaptic vesicle endocytosis in neuronal cells and endocytic recycling of C. elegans yolk receptors RME-2 (Allaire et al., 2006; Sato et al., 2008) . DENND1C, through Rab35, regulates membrane extensions by co-localizing with fascin and actin filaments (Marat et al., 2012) . Alternatively, T H cells may also have evolved lineage-specific mechanisms for TCR internalization to accommodate their different biological functions. Antigen affinity for TCR, avidity of APC, and T cell interactions modulated by co-receptors and accessory molecules as well as cell-cycle regulation through epigenetic modification have been demonstrated to contribute to skewing of T H 1 and T H 2 cell development (reviewed in Constant and Bottomly, 1997) . Our studies suggest that once epigenetic control of T H differentiation has been established, the kinetics of TCR downmodulation and, in turn, TCR signaling duration and output strength are uniquely regulated by DENND1B in T H 2 cells when compared to T H 0, T H 1, and T H 17 lineage cells. Since distinct transcription factors (e.g., BATF3, IRF4, and KLF4) control differentiation of DC subsets that specifically promote T H 1, T H 2, or T H 17 responses (reviewed in Belz and Nutt, 2012) , each T H lineage may also have developed lineage-specific mechanisms to fine-tune TCR downmodulation and signaling duration to adapt to their unique biological functions.
An additional observation in both T H 1 and T H 2 cells was the differential effects of TCR downmodulation on IL-2 versus T H effector cytokines. While TCR downmodulation is delayed and (legend continued on next page) T H 2 effector cytokines are increased in Dennd1b À/À T H 2 cells or T H 2 cells in which AP-2 or Rab35 are knocked down by siRNA, IL-2 production is not affected. Similarly, in T H 1 cells, while AP-2 knockdown by siRNA results in delayed TCR downmodulation and increased IFN-g production, IL-2 production is not affected. The lack of effect on IL-2 production is not due to supra-optimal anti-CD3/28 mAb stimulation, as no differences in IL-2 production are observed between Dennd1b +/+ and Figure S7 .
required for IL-2 as compared to the NF-AT, GATA3, c-MAF, and KLF13 transcriptional machinery required for IL-4 (reviewed in Ansel et al., 2006) . Additionally, while IL-2 production is controlled in a digital signaling fashion through NFkB, NFAT and other signaling pathways (Kingeter et al., 2010; Huang et al., 2013; Navarro et al., 2014) , the nature of signal amplification (i.e., digital versus analog) for IL-4 is not well understood and requires further investigation. Finally, the subcellular localization of signaling may also differentially regulate the production of IL-2 versus lineage-specific cytokines. Phosphorylated CD3z and presumably activated TCR complexes have been observed in the endosomal compartment (Yudushkin and Vale, 2010) and may further contribute to a sustained TCR signal required for IL-2 production (Huppa et al., 2003) .
Taken together, our studies demonstrate an important role for DENND1B in TCR downmodulation specifically in T H 2 cells through its interactions with AP-2/clathrin and its GEF activity, likely via Rab35. These experimental data provide a framework by which other DENN-domain-containing proteins may regulate yet-to-be identified receptor systems to maintain homeostasis and, when dysregulated, contribute to disease. Moreover, this paradigm further substantiates how alterations in duration and/ or subcellular localization of signaling may alter biological consequences to contribute to disease pathogenesis.
EXPERIMENTAL PROCEDURES Quantitation of Plasma Membrane TCRs
Murine T H lineage cultures (2 3 10 6 cells) were treated with biotin-labeled anti-CD3ε (10 mg/ml, clone 2C11) and anti-CD28 (2 mg/ml, non-biotinylated, clone 37.51) mAbs for 30 min on ice. For human T H lineage cultures, cells (2 3 10 6 cells) were treated with biotin-labeled anti-CD3ε (10 mg/ml, clone UCHT1) and anti-CD28 (2 mg/ml, non-biotinylated, clone CD28.2) mAbs for 30 min on ice. Following wash to rid of unbound mAbs, cells were incubated at 37 C for the indicated times and then transferred to 4 C to terminate receptor internalization. Remaining surface TCRs were quantitated by FACS analysis using streptavidin-conjugated APC (allophycocyanin). For antigen stimulation, T H lineage cultures (2 3 10 6 cells) derived from splenic CD4 + naive T cells of 
TNP-OVA-Induced Airway Inflammation
Eight-week-old female mice were sensitized by intraperitoneal injection of TNP-OVA (50 mg) in alum (2 mg). Thirty-five days later, the mice were challenged for 7 consecutive days with 1% TNP-OVA aerosol in PBS for 30 min via a nebulizer. Spleens, lungs, mediastinal lymph nodes, BALF, and sera were collected 24 hr after the last challenge for further experimental studies. The experiments were conducted in compliance with National Institute of Health Guide for the Care and Use of Laboratory Animals and experimental protocols approved by Genentech Institutional Care and Use Committee.
Statistical Analysis
All analysis except eQTL were presented as mean ± S.D. Statistical analysis was processed by Mann-Whitney testing using Prism 6 software (GraphPad). Statistical significance of p values are indicated with asterisks (*p < 0.05; **p < 0.01; ***p < 0.001). 
SUPPLEMENTAL INFORMATION
